penicillamine
Showing 1 - 25 of 33
Head Neck Cancer, Recurrent Cancer Trial in Guangzhou (Penicillamine)
Not yet recruiting
- Head and Neck Cancer
- Recurrent Cancer
- Penicillamine
-
Guangzhou, Guangdong, ChinaSouthern medical university
Oct 24, 2023
Cystinuria Trial in New York (Tiopronin 1g per day, Tiopronin 2g per day, Tiopronin 3g per day)
Completed
- Cystinuria
- Tiopronin 1g per day
- +2 more
-
New York, New YorkNYU Langone Medical Center
Jul 28, 2021
Real World Evidence Study in Subjects With Wilson's Disease
Not yet recruiting
- Wilson Disease
- NCC-Sp Assay
- (no location specified)
Mar 23, 2023
Wilson's Disease Trial in Hangzhou (DMPS, Penicillamine, DMSA)
Recruiting
- Wilson's Disease
- DMPS
- +3 more
-
Hangzhou, Zhejiang, Chinaecond Affiliated Hospital,Zhejiang University School of Medicine
May 19, 2019
Wilson's Disease Trial in Paris
Recruiting
- Wilson's Disease
-
Leuven, Belgium
- +13 more
Jan 9, 2023
Sun Damaged Skin Trial in Sacramento (Zinc Oxide and Avobenzone)
Completed
- Sun Damaged Skin
- Zinc Oxide and Avobenzone
-
Sacramento, CaliforniaUniversity of California, Davis
May 9, 2023
Wilson Disease Trial in Worldwide (Bis-Choline Tetrathiomolybdate)
Active, not recruiting
- Wilson Disease
- Bis-Choline Tetrathiomolybdate
-
Sacramento, California
- +10 more
Jan 26, 2023
Wilson Disease Trial in Worldwide (ALXN1840, SoC Therapy)
Active, not recruiting
- Wilson Disease
- ALXN1840
- SoC Therapy
-
Los Angeles, California
- +53 more
May 2, 2022
After Changing Medication From Nonselective to Selective
Not yet recruiting
- Eisenmenger Complex
- (no location specified)
Jan 26, 2021
Copper Parameters in Wilson Disease Participants on Standard of
Completed
- Wilson Disease
- Standard of Care Medications
-
New Haven, Connecticut
- +9 more
Nov 16, 2020
Wilson Disease Trial in New Haven (Once a day Trientine)
Completed
- Wilson Disease
- Once a day Trientine
-
New Haven, ConnecticutYale University
Apr 1, 2020
Wilson Disease Trial in Worldwide (trientine diHCl)
Unknown status
- Wilson Disease
- trientine dihydrochloride
-
Heidelberg, Germany
- +3 more
Aug 22, 2017
Ovarian Tumors Malignant (Excl Germ Cell), Peritoneal Carcinoma, Fallopian Tube Cancer Trial (trientine diHCl, pegylated
Completed
- Ovarian Neoplasms Malignant (Excl Germ Cell)
- +2 more
- trientine dihydrochloride
- +2 more
- (no location specified)
Oct 18, 2020
Arteriovenous Fistula Occlusion Trial in Chattanooga (Placebo, Ascorbic Acid, Cuprimine Oral Product)
Unknown status
- Arteriovenous Fistula Occlusion
- Placebo
- +2 more
-
Chattanooga, TennesseeSoutheast Renal Research Institute
Sep 6, 2017
Cystine Capacity Clinical Study (CysCap)
Completed
- Cystinuria
-
New York, New YorkNYU Langone Medical Center
Nov 29, 2018
Myofascial Pain, Temporomandibular Disorder Trial in Ankara (Occlusal Splint, Botulinum toxin type A)
Completed
- Myofascial Pain
- Temporomandibular Disorder
- Occlusal Splint
- Botulinum toxin type A
-
Ankara, TurkeyAnkara University, Faculty of Dentistry
Mar 25, 2019
Systemic Sclerosis, Scleroderma Trial in Philadelphia (Ambrisentan)
Completed
- Systemic Sclerosis
- Scleroderma
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Health System
Nov 26, 2018
Lead Poisoning, Vitamin D Deficiency Trial in Boston (d-penicillamine, )
Withdrawn
- Lead Poisoning
- Vitamin D Deficiency
- d-penicillamine
- placebo
-
Boston, MassachusettsChildren's Hospital Boston
Mar 24, 2015
Systemic Sclerosis Trial in London (Fibrogammin®P, coagulation factor XIII concentrate (Human), 0.9% sodium chloride)
Unknown status
- Systemic Sclerosis
- Fibrogammin®P, coagulation factor XIII concentrate (Human)
- 0.9% sodium chloride
-
London, United KingdomRoyal Free London NHS Foundation Trust
May 27, 2016